SCHEMBL8895032

SCHEMBL8895032

CCc1ccnc(I)c1C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
METAP2 P50579 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35
GABRQ Q9UN88 1/20 0.35
FTO Q9C0B1 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7259052 0.79 KDM4E (0.40) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL9139692 0.79 ALDH1A1 (0.39) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL27775355 0.79 GABRP (0.40) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL10694897 0.79 KDM4E (0.47) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL1997421 0.79 METAP2 (0.42) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL311734 0.78 SMN1; SMN2 (0.43) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL10718190 0.78 NOS2 (0.43) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL18795788 0.78 METAP2 (0.35) ALDH1A1KDM4EMETAP2GABRPGABRD
Hydrochloric Acid SCHEMBL27754730 0.78 GABRP (0.39) ALDH1A1KDM4EMETAP2GABRPGABRD
SCHEMBL8645026 0.78 KDM4E (0.46) ALDH1A1KDM4EMETAP2GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5672710-A SPECIFIC AGONISTS FOR THE RXR RETINOID RECEPTOR RATHER THAN THE RAR ONE; SIDE EFFECT REDUCTION; SKIN AND NERVOUS SYTEM DISORDERS; ANTICARCINOGENIC AGENTS; VISION DEFECTS ALLERGAN (US) 1997-09-30 US disclosed
WO-1997016422-A1 SULFIDES, SULFOXIDES AND SULFONES DISUBSTITUTED WITH A TETRAHYDRONAPHTHALENYL, CHROMANYL, THIOCHROMANYL OR TETRAHYDROQUINOLINYL AND SUBSTITUTED PHENYL OR HETEROARYL GROUP, HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN (US) 1997-05-09 WO disclosed